(Q36053831)

11 August 2017

Ketoconazole inhibits the metabolism of tolterodine in subjects with deficient CYP2D6 activity (English)

1 reference

11 August 2017

Gustafsson LL

4

0 references

author name string

Brynne N

1

1 reference

11 August 2017

Forslund C

2

1 reference

11 August 2017

Hallén B

3

1 reference

11 August 2017

Bertilsson L

5

1 reference

11 August 2017

language of work or name

English

0 references

publication date

1 October 1999

1 reference

British Journal of Clinical Pharmacology

11 August 2017

1 reference

11 August 2017

48

1 reference

11 August 2017

4

1 reference

11 August 2017

564-572

1 reference

Fluoxetine inhibits the metabolism of tolterodine-pharmacokinetic implications and proposed clinical relevance

11 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014365

Tolterodine in the treatment of overactive bladder: analysis of the pooled phase II efficacy and safety data

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014365

Dose-ranging study of tolterodine in patients with detrusor hyperreflexia

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014365

Effects of ketoconazole on digoxin absorption and disposition in rat.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014365

Drug interactions with grapefruit juice

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014365

Cytochrome P4503A (CYP3A) metabolism: prediction of in vivo activity in humans

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014365

Oral triazolam is potentially hazardous to patients receiving systemic antimycotics ketoconazole or itraconazole

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014365

Antimuscarinic potency and bladder selectivity of PNU-200577, a major metabolite of tolterodine

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014365

Efficacy and safety of two doses of tolterodine versus placebo in patients with detrusor overactivity and symptoms of frequency, urge incontinence, and urgency: urodynamic evaluation. The International Study Group.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014365

Influence of CYP2D6 polymorphism on the pharmacokinetics and pharmacodynamic of tolterodine

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014365

Oral triazolam is potentially hazardous to patients receiving systemic antimycotics ketoconazole or itraconazole

23 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1046%2FJ.1365-2125.1999.00053.X

Pharmacokinetics and pharmacodynamics of tolterodine in man: a new drug for the treatment of urinary bladder overactivity

21 January 2018

1 reference

12 December 2020

Tolterodine--a new bladder-selective antimuscarinic agent

1 reference

12 December 2020

Determination of tolterodine and the 5-hydroxymethyl metabolite in plasma, serum and urine using gas chromatography-mass spectrometry

1 reference

12 December 2020

Efficacy and safety of tolterodine in patients with detrusor instability: a dose-ranging study

1 reference

12 December 2020

Tolterodine, a new muscarinic receptor antagonist, is metabolized by cytochromes P450 2D6 and 3A in human liver microsomes

1 reference

12 December 2020

Serum protein binding of tolterodine and its major metabolites in humans and several animal species

1 reference

12 December 2020

Effect of ketoconazole on hepatic oxidative drug metabolism

1 reference

12 December 2020

Effects of ketoconazole on methylprednisolone pharmacokinetics and cortisol secretion

1 reference

12 December 2020

Determination of ketoconazole in the plasma, liver, lung and adrenal of the rat by high-performance liquid chromatography

1 reference

12 December 2020

Ketoconazole does not impair antipyrine clearance in humans

1 reference

12 December 2020

Effects of imidazole derivatives on cytochromes P450 from human hepatocytes in primary culture

1 reference

12 December 2020

Itraconazole prevents terfenadine metabolism and increases risk of torsades de pointes ventricular tachycardia

1 reference

12 December 2020

10.1046/J.1365-2125.1999.00053.X

Identifiers

DOI

1 reference

11 August 2017

1 reference

11 August 2017

PubMed publication ID

10583027

1 reference